Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan during emergency PCI for acute myocardial infarction
ChiCTR1900020994Phase 4Not yet recruiting
- Sponsor
- Qingdao Municipal Hospital
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levosimendan in myocardial infarction (MI) (2 arms), sponsored by Qingdao Municipal Hospital. Primary endpoints: Heart function, Myocardial infarction area and 2 more. Planned start Feb 2019; status: not yet recruiting.
02
Drugs
levosimendan
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR1900020994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020994.